Cytori Therapeutics Garners $15,000,000 New Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=630ed075-4f50-4800-88c6-fae07fac0190&Preview=1 -
Date
10/15/2008 -
Company Name
Cytori Therapeutics -
Mailing Address
3020 Callan Road San Diego, CA 92121 -
Company Description
Cytori Therapeutics’ (Nasdaq: CYTX) goal is to be the global leader in regenerative medicine. Cytori is dedicated to providing patients with new options for reconstructive and aesthetic surgery, developing treatments for cardiovascular disease, and banking patients’ adipose-derived, adult stem and regenerative cells (ADRCs). -
Website
http://www.cytoritx.com -
Transaction Type
Debt -
Transaction Amount
$15,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
The investment will be used to support the commercialization of Cytori’s recently launched Celution® System and StemSource® Cell Bank in Europe and Asia. In addition, the funds will support product pipeline development and general corporate activities. Securing this loan facility further demonstrates Cytori’s ability to attract funding from well regarded sources. -
M&A Terms
-
Venture Investor
GE Healthare Financial Services -
Venture Investor
Silicon Valley Bank
